D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Price:
106 900
VND
-0.09%
Market Cap:
14T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DHG Alert
Dhg Pharmaceutical Joint-Stock Co
106900
-100 (-0.09%)
| 52 Week Range |
105 500
120 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Dhg Pharmaceutical Joint-Stock Co
Balance Sheet
Balance Sheet Decomposition
Dhg Pharmaceutical Joint-Stock Co
Dhg Pharmaceutical Joint-Stock Co
| Current Assets | 4.7T |
| Cash & Short-Term Investments | 2.7T |
| Receivables | 532.6B |
| Other Current Assets | 1.5T |
| Non-Current Assets | 1.4T |
| Long-Term Investments | 35.6B |
| PP&E | 1.2T |
| Intangibles | 180B |
| Other Non-Current Assets | 78.4B |
| Current Liabilities | 1.8T |
| Accounts Payable | 224.4B |
| Accrued Liabilities | 232.7B |
| Short-Term Debt | 810.9B |
| Other Current Liabilities | 564.2B |
| Non-Current Liabilities | 69.5B |
| Other Non-Current Liabilities | 69.5B |
Balance Sheet
Dhg Pharmaceutical Joint-Stock Co
Dhg Pharmaceutical Joint-Stock Co
Currency: VND
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
613 287
|
496 492
|
420 713
|
603 189
|
549 777
|
75 836
|
70 328
|
0
|
0
|
94 134
|
|
| Cash |
197 503
|
108 745
|
89 511
|
270 265
|
88 443
|
75 330
|
66 628
|
0
|
0
|
94 134
|
|
| Cash Equivalents |
415 784
|
387 747
|
331 202
|
332 924
|
461 334
|
505
|
3 700
|
0
|
0
|
0
|
|
| Short-Term Investments |
170 000
|
260 617
|
507 605
|
703 731
|
930 615
|
1 459 722
|
1 768 000
|
2 110 000
|
2 355 000
|
2 230 000
|
|
| Total Receivables |
573 939
|
798 878
|
626 458
|
678 802
|
794 252
|
690 298
|
524 860
|
397 658
|
377 553
|
675 203
|
|
| Accounts Receivables |
505 610
|
753 017
|
559 843
|
609 256
|
717 568
|
583 932
|
454 884
|
315 113
|
279 862
|
528 859
|
|
| Other Receivables |
68 329
|
45 861
|
66 615
|
69 546
|
76 684
|
106 366
|
69 976
|
82 545
|
97 690
|
146 344
|
|
| Inventory |
757 949
|
780 704
|
639 321
|
732 861
|
633 808
|
891 487
|
725 439
|
1 072 606
|
1 250 834
|
1 534 636
|
|
| Other Current Assets |
117 384
|
49 560
|
27 277
|
27 490
|
30 732
|
30 294
|
45 297
|
103 656
|
201 368
|
108 219
|
|
| Total Current Assets |
2 232 558
|
2 386 250
|
2 221 373
|
2 746 073
|
2 939 185
|
3 147 636
|
3 133 924
|
3 720 883
|
4 218 772
|
4 642 193
|
|
| PP&E Net |
623 097
|
783 797
|
827 079
|
858 630
|
821 517
|
755 187
|
718 592
|
631 658
|
678 171
|
1 187 884
|
|
| PP&E Gross |
623 097
|
783 797
|
827 079
|
858 630
|
821 517
|
755 187
|
718 592
|
631 658
|
678 171
|
1 187 884
|
|
| Accumulated Depreciation |
282 726
|
357 083
|
440 755
|
515 345
|
592 766
|
606 606
|
686 346
|
833 289
|
896 228
|
970 764
|
|
| Intangible Assets |
175 986
|
180 017
|
256 418
|
261 965
|
241 790
|
235 520
|
210 452
|
205 780
|
201 812
|
181 861
|
|
| Note Receivable |
0
|
0
|
0
|
5 099
|
3 510
|
1 560
|
459
|
642
|
822
|
205
|
|
| Long-Term Investments |
20 765
|
16 842
|
15 932
|
15 744
|
14 538
|
25 468
|
43 468
|
22 493
|
18 169
|
35 656
|
|
| Other Long-Term Assets |
28 214
|
115 812
|
42 397
|
57 831
|
66 940
|
40 594
|
39 922
|
33 061
|
50 440
|
62 675
|
|
| Total Assets |
3 080 620
N/A
|
3 482 718
+13%
|
3 363 199
-3%
|
3 945 342
+17%
|
4 087 480
+4%
|
4 205 964
+3%
|
4 146 819
-1%
|
4 614 517
+11%
|
5 168 187
+12%
|
6 110 474
+18%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
267 948
|
261 374
|
224 957
|
291 703
|
262 987
|
145 750
|
120 317
|
201 220
|
364 379
|
217 976
|
|
| Accrued Liabilities |
508 545
|
541 301
|
240 493
|
268 137
|
284 346
|
263 432
|
241 915
|
238 288
|
215 326
|
296 862
|
|
| Short-Term Debt |
127 031
|
176 707
|
270 711
|
354 765
|
469 800
|
557 901
|
264 667
|
207 391
|
114 723
|
572 165
|
|
| Other Current Liabilities |
126 718
|
140 307
|
43 471
|
103 353
|
247 804
|
34 404
|
78 001
|
110 801
|
117 108
|
102 239
|
|
| Total Current Liabilities |
1 030 242
|
1 119 689
|
779 632
|
1 017 959
|
1 264 937
|
1 001 488
|
704 899
|
757 700
|
811 537
|
1 189 242
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
18 077
|
16 830
|
20 323
|
34 160
|
11 671
|
9 534
|
5 410
|
0
|
0
|
0
|
|
| Other Liabilities |
50 936
|
69 403
|
62 330
|
57 600
|
63 449
|
60 215
|
64 368
|
66 807
|
65 113
|
68 298
|
|
| Total Liabilities |
1 099 255
N/A
|
1 205 923
+10%
|
862 286
-28%
|
1 109 719
+29%
|
1 340 057
+21%
|
1 071 237
-20%
|
774 677
-28%
|
824 507
+6%
|
876 650
+6%
|
1 257 540
+43%
|
|
| Equity | |||||||||||
| Common Stock |
653 764
|
871 643
|
871 643
|
871 643
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
|
| Retained Earnings |
559 731
|
556 467
|
605 911
|
736 639
|
321 006
|
550 253
|
665 298
|
807 129
|
1 018 364
|
1 080 572
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
|
| Treasury Stock |
456
|
456
|
16 121
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
768 327
|
849 140
|
1 039 479
|
1 220 562
|
1 112 177
|
1 270 236
|
1 392 604
|
1 668 641
|
1 958 933
|
2 458 123
|
|
| Total Equity |
1 981 365
N/A
|
2 276 795
+15%
|
2 500 913
+10%
|
2 835 623
+13%
|
2 747 423
-3%
|
3 134 728
+14%
|
3 372 142
+8%
|
3 790 010
+12%
|
4 291 537
+13%
|
4 852 935
+13%
|
|
| Total Liabilities & Equity |
3 080 620
N/A
|
3 482 718
+13%
|
3 363 199
-3%
|
3 945 342
+17%
|
4 087 480
+4%
|
4 205 964
+3%
|
4 146 819
-1%
|
4 614 517
+11%
|
5 168 187
+12%
|
6 110 474
+18%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
131
|
131
|
130
|
131
|
131
|
131
|
131
|
131
|
131
|
131
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
